Related Experiment Video
Updated: Aug 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Antithrombotic treatment of acute coronary syndrome]
1Zavod za bolesti srca i krvnih zila, Interna klinika Medicinskog fakulteta Sveucilista u Zagrebu, Klinicka bolnica Dubrava, Avenija G. Suska 6 10000 Zagreb, Hrvatska. mijo.bergovec@usa.net
Insights
Antithrombotic therapy is crucial for managing acute coronary syndrome, a condition often caused by blocked coronary arteries due to arteriosclerosis. Advances in treatments like anticoagulants and antiplatelets have significantly improved patient outcomes over the last 30 years.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Arteriosclerosis is a primary cause of coronary artery occlusion, leading to thrombotic and thromboembolic events.
- Acute coronary syndrome (ACS) management has seen significant advancements in antithrombotic strategies over the past three decades.
Purpose of the Study:
- To review major studies and international guidelines on antithrombotic treatment for ACS.
- To highlight the evolution and current state of antithrombotic therapies in managing ACS.
Main Methods:
- Review of major clinical studies and treatment guidelines.
- Analysis of various antithrombotic therapeutic approaches.
Main Results:
- Antithrombotic therapy is established as the cornerstone of ACS management.
- Key therapeutic directions include thrombolytic therapy, heparin anticoagulation, glycoprotein IIb/IIIa inhibitors, and antiplatelet agents (aspirin, tienopyridines).
Conclusions:
- Significant improvements in antithrombotic treatments have been achieved for ACS.
- Current guidelines emphasize a multifaceted antithrombotic approach for optimal patient care.
Abstract:
After we have become aware that arteriosclerosis provokes thrombotic and thromboembolic process, which is the most common cause of occlusion of coronary arteries, in the past 30 years significant improvements have been made in antithrombotic treatment of acute coronary syndrome. Antithrombotic therapy of acute coronary syndrome has been explored in few directions. These are thrombolytic multidrug therapy, anticoagulant therapy with nonfractional and low molecular heparin, therapy with glycoprotein IIb/IIIa receptor antagonists and antiaggregation therapy with acetylsalicylic acid and tienopyrid. Research results and clinical experience point to a conclusion that antithrombotic therapy is the cornerstone in the mariagement of acute coronary syndrome. In this paper, results of major studies and main antithrombotic treatment guidelines in acute coronary syndrome accepted by international professional associations are presented.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management